- Tilray launched products through licensed retailers in Canada on May 28, 2026.
- Tilray, a company based in Canada, has begun exporting medical-grade cannabis products to markets in Europe.
Tilray's clinic participated in an Aldershot event while expanding regulated access across the UK.
3 reports, 1 independent
Updated Jul 3
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Tilray's clinic participated in an Aldershot event while expanding regulated access across the UK.
Who's involved
What this event is mainly aboutKeep exploring
Part of
Tilray, a company based in Canada, has begun exporting medical-grade cannabis products to markets in Europe.Also in this story
- Tilray secured a partnership to distribute medical cannabis products in Italy, while Trump's administration considers reclassifying cannabis.
- Tilray launched new medical cannabis strains in Germany, aiming to improve access in Europe's largest market.
- Tilray is expanding its global operational footprint, confirming presence in Europe, Latin America, the United States, Canada, Australia, and Europe.
Within Tilray launched products through licensed retailers in Canada on May 28, 2026.
The entities involved
-
Tilray
pharmaceutical and cannabis company